Accueil   Diary - News   All news Adocia and Lilly initiate Phase 1b

Adocia and Lilly initiate Phase 1b

Adocia (Euronext Paris: ADOC) and Eli Lilly and Company (NYSE: LLY) announced the initiation of a Phase 1b clinical trial evaluating BioChaperone Lispro, an ultra-rapid formulation of insulin lispro licensed to Lilly. This formulation uses Adocia’s proprietary technology, BioChaperone®, which is designed to enable the acceleration of insulin absorption.

 

 

Read the press release